Adage Capital Partners
ANGO icon

Adage Capital Partners’s AngioDynamics ANGO Stock Holding History

Adage Capital Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-150,000
Closed -$1.68M – 917
2025
Q3 		$1.68M Buy
150,000
+50,000
+50% +$483K ﹤0.01% 817
2025
Q2 		$992K Hold
100,000
– – ﹤0.01% 796
2025
Q1 		$939K Buy
+100,000
New +$1.05M ﹤0.01% 798
2022
Q4 		– Sell
-700,000
Closed -$14.3M – 981
2022
Q3 		$14.3M Sell
700,000
-300,000
-30% -$6.59M 0.04% 531
2022
Q2 		$19.4M Sell
1,000,000
-182,707
-15% -$3.74M 0.04% 440
2022
Q1 		$25.5M Sell
1,182,707
-242,293
-17% -$5.5M 0.05% 390
2021
Q4 		$39.3M Buy
1,425,000
+125,000
+10% +$3.45M 0.07% 286
2021
Q3 		$33.7M Buy
1,300,000
+100,000
+8% +$2.67M 0.07% 298
2021
Q2 		$32.6M Buy
1,200,000
+125,000
+12% +$3.05M 0.06% 316
2021
Q1 		$25.2M Buy
+1,075,000
New +$21.7M 0.05% 373

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KK
Kotler Kevin $427M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Adage Capital Partners's ANGO Position: Q4 2025 in Review

Adage Capital Partners sold out of AngioDynamics (ANGO) in Q4 2025, closing a stake of 150,000 shares — an estimated $1.68M sold.

Adage Capital Partners first reported a position in ANGO in Q1 2021 and held it in 10 quarters. The position peaked at $39.3M in Q4 2021. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

  • Adage Capital Partners reported no remaining AngioDynamics position as of Q4 2025 after selling out during the quarter.
  • Adage Capital Partners sold 150,000 AngioDynamics shares in Q4 2025, an estimated $1.68M.
  • Adage Capital Partners first reported a position in AngioDynamics in Q1 2021 and held it in 10 quarters.
  • Adage Capital Partners's AngioDynamics position peaked at $39.3M in Q4 2021.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on Adage Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.